Clinical Trials on Alzheimer's Disease (CTAD) 2022
San Francisco, California
–
Conference Coverage
San Diego, California and Online
–
Barcelona, Spain
–
The 16th International AD/PD meeting was also the first hybrid version, drawing some 3,360 participants online, or in person in Barcelona, Spain. Scientists outlined Roche’s new Phase 3 secondary prevention trial of gantenerumab for the first time. Attendees also heard updates on Aduhelm, lecanemab, and α-synuclein immunotherapy. On the basic science front, tau emerged as an instigator of interferon responses, while presentations on postmortem single-nuclei data showed how collectives of cell subtypes, and their cross talk, wax and wane together with age and with AD pathology.
The Alzforum team brings you news from more than 20 conferences a year
Conference Calendar
Upcoming conferences on AD and related fields.View conference calendar